Base Excision Repair: Contribution to Tumorigenesis and Target in Anticancer Treatment Paradigms
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
3922-3936
Author(s):
J. L. Illuzzi and D. M. Wilson III
The Role of Bacterial Lipopolysaccharides as Immune Modulator in Vaccine and Drug Development
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
12
Page:
221-235
Author(s):
Jesus Arenas
Antigen-specific Immunotherapy in Ovarian Cancer and p53 as Tumor Antigen
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
3804-3811
Author(s):
Renee Vermeij, Ninke Leffers, Cornelis J. Melief, Toos Daemen and Hans W. Nijman
Patent Selections:
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
7
Page:
345-346
Author(s):
Bentham Science Publishers
Proteins Expressed Differently Between Glucose and Glycerol for Schizochytrium limacinum SR21
Journal:
Current Biotechnology
Volume:
1
Page:
227-233
Author(s):
Yanna Liang and Nicolas Sarkany
The Effects of Curcumin on Immune Responses
Journal:
Current Bioactive Compounds
Volume:
8
Page:
142-145
Author(s):
Antonio La Cava
Prophylactic Vaccine Approach for Colon and Pancreatic Cancers: Present and Future
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
3664-3678
Author(s):
N. B. Janakiram, A. Mohammed, M. S. Bronze and C. V. Rao
Expression of Specificity Protein Transcription Factors in Pancreatic Cancer and their Association in Prognosis and Therapy
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
3779-3786
Author(s):
Umesh T. Sankpal, Pius Maliakal, Debashish Bose, Omar Kayaleh, Daniel Buchholz and Riyaz Basha
Melatonin, A Natural Programmed Cell Death Inducer in Cancer
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
3805-3821
Author(s):
M. Sánchez-Hidalgo, J. M. Guerrero, I. Villegas, G. Packham and C. A. de la Lastra
Namitecan: a Hydrophilic Camptothecin with a Promising Preclinical Profile
Journal:
Current Medicinal Chemistry
Volume:
19
Page:
3488-3501
Author(s):
G. L. Beretta, V. Zuco, M. De Cesare, P. Perego and N. Zaffaroni